Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Stem Cell Transplant for Advanced Solid Tumors
NCT00523809Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2007
- Primary completion
- Oct 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, ovarian cancer, renal cell carcinoma (RCC), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2007; status: terminated.
02
Drugs
bevacizumab
03
Conditions
breast cancerovarian cancerrenal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00523809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523809.